ID   MA7D2_HUMAN             Reviewed;         732 AA.
AC   Q96T17; B7Z2J8; B7Z3S7; B9EGC7; C9JMA4; C9JYW0; Q5EBN1; Q5JPS7; Q6PIC7;
AC   Q8N792;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   18-JUN-2025, entry version 146.
DE   RecName: Full=MAP7 domain-containing protein 2;
GN   Name=MAP7D2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 67-732 (ISOFORM 3).
RC   TISSUE=Brain, Teratocarcinoma, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-182.
RC   TISSUE=Liver, Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 5), AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-32.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=30784582; DOI=10.1016/j.celrep.2019.01.084;
RA   Pan X., Cao Y., Stucchi R., Hooikaas P.J., Portegies S., Will L.,
RA   Martin M., Akhmanova A., Harterink M., Hoogenraad C.C.;
RT   "MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-
RT   Mediated Cargo Transport into the Axon.";
RL   Cell Rep. 26:1988-1999.e6(2019).
CC   -!- FUNCTION: Microtubule-stabilizing protein that plays a role in the
CC       control of cell motility and neurite outgrowth via direct binding to
CC       the microtubule (By similarity). Acts as a critical cofactor for
CC       kinesin transport. In the proximal axon, regulates kinesin-1 family
CC       members, KIF5A, KIF5B and KIF5C recruitment to microtubules and
CC       contributes to kinesin-1-mediated transport in the axons (By
CC       similarity). {ECO:0000250|UniProtKB:A2AG50,
CC       ECO:0000250|UniProtKB:D4A4L4}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with microtubules; facilitates
CC       microtubule stabilization. Interacts with kinesin-1 family members,
CC       KIF5A, KIF5B and KIF5C. {ECO:0000250|UniProtKB:D4A4L4}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000250|UniProtKB:A2AG50}. Midbody
CC       {ECO:0000250|UniProtKB:A2AG50}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:A2AG50}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:A2AG50}. Cell projection, axon
CC       {ECO:0000269|PubMed:30784582}. Note=Strongly localizes to the
CC       centrosome and partially on microtubule. During cytokinesis,
CC       accumulates at the midbody (By similarity). Accumulates to the proximal
CC       part of the axon (PubMed:30784582). {ECO:0000250|UniProtKB:A2AG50,
CC       ECO:0000269|PubMed:30784582}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q96T17-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96T17-2; Sequence=VSP_028492;
CC       Name=3;
CC         IsoId=Q96T17-3; Sequence=VSP_028490, VSP_028491, VSP_028493;
CC       Name=4;
CC         IsoId=Q96T17-4; Sequence=VSP_043337;
CC       Name=5;
CC         IsoId=Q96T17-5; Sequence=VSP_044657, VSP_044658;
CC   -!- SIMILARITY: Belongs to the MAP7 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC05407.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK027409; BAB55093.1; -; mRNA.
DR   EMBL; AK098768; BAC05407.1; ALT_INIT; mRNA.
DR   EMBL; AK294788; BAH11884.1; -; mRNA.
DR   EMBL; AK296319; BAH12313.1; -; mRNA.
DR   EMBL; AL732366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC037165; AAH37165.1; -; mRNA.
DR   EMBL; BC089400; AAH89400.1; -; mRNA.
DR   EMBL; BC136379; AAI36380.1; -; mRNA.
DR   CCDS; CCDS14195.1; -. [Q96T17-1]
DR   CCDS; CCDS55384.1; -. [Q96T17-5]
DR   CCDS; CCDS55385.1; -. [Q96T17-4]
DR   CCDS; CCDS55386.1; -. [Q96T17-2]
DR   RefSeq; NP_001161937.1; NM_001168465.2. [Q96T17-2]
DR   RefSeq; NP_001161938.1; NM_001168466.2. [Q96T17-4]
DR   RefSeq; NP_001161939.1; NM_001168467.2. [Q96T17-5]
DR   RefSeq; NP_689993.2; NM_152780.4. [Q96T17-1]
DR   AlphaFoldDB; Q96T17; -.
DR   SMR; Q96T17; -.
DR   BioGRID; 129178; 93.
DR   FunCoup; Q96T17; 447.
DR   IntAct; Q96T17; 43.
DR   MINT; Q96T17; -.
DR   STRING; 9606.ENSP00000368964; -.
DR   iPTMnet; Q96T17; -.
DR   PhosphoSitePlus; Q96T17; -.
DR   BioMuta; MAP7D2; -.
DR   DMDM; 296434580; -.
DR   jPOST; Q96T17; -.
DR   MassIVE; Q96T17; -.
DR   PaxDb; 9606-ENSP00000368964; -.
DR   PeptideAtlas; Q96T17; -.
DR   ProteomicsDB; 12313; -.
DR   ProteomicsDB; 78169; -. [Q96T17-1]
DR   ProteomicsDB; 78170; -. [Q96T17-2]
DR   ProteomicsDB; 78171; -. [Q96T17-3]
DR   ProteomicsDB; 78172; -. [Q96T17-4]
DR   Pumba; Q96T17; -.
DR   Antibodypedia; 63281; 12 antibodies from 7 providers.
DR   DNASU; 256714; -.
DR   Ensembl; ENST00000379643.10; ENSP00000368964.5; ENSG00000184368.16. [Q96T17-2]
DR   Ensembl; ENST00000379651.7; ENSP00000368972.3; ENSG00000184368.16. [Q96T17-1]
DR   Ensembl; ENST00000443379.7; ENSP00000388239.3; ENSG00000184368.16. [Q96T17-4]
DR   Ensembl; ENST00000452324.3; ENSP00000413301.3; ENSG00000184368.16. [Q96T17-5]
DR   GeneID; 256714; -.
DR   KEGG; hsa:256714; -.
DR   MANE-Select; ENST00000379643.10; ENSP00000368964.5; NM_001168465.2; NP_001161937.1. [Q96T17-2]
DR   UCSC; uc004czr.3; human. [Q96T17-1]
DR   AGR; HGNC:25899; -.
DR   CTD; 256714; -.
DR   DisGeNET; 256714; -.
DR   GeneCards; MAP7D2; -.
DR   HGNC; HGNC:25899; MAP7D2.
DR   HPA; ENSG00000184368; Tissue enhanced (brain, epididymis).
DR   MIM; 301121; gene.
DR   OpenTargets; ENSG00000184368; -.
DR   VEuPathDB; HostDB:ENSG00000184368; -.
DR   eggNOG; ENOG502QTSG; Eukaryota.
DR   GeneTree; ENSGT00950000182941; -.
DR   HOGENOM; CLU_017315_1_0_1; -.
DR   InParanoid; Q96T17; -.
DR   OMA; QMEPPMS; -.
DR   OrthoDB; 9950098at2759; -.
DR   PAN-GO; Q96T17; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q96T17; -.
DR   PathwayCommons; Q96T17; -.
DR   SignaLink; Q96T17; -.
DR   BioGRID-ORCS; 256714; 13 hits in 766 CRISPR screens.
DR   ChiTaRS; MAP7D2; human.
DR   GenomeRNAi; 256714; -.
DR   Pharos; Q96T17; Tdark.
DR   PRO; PR:Q96T17; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q96T17; protein.
DR   Bgee; ENSG00000184368; Expressed in Brodmann (1909) area 23 and 135 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; ISS:UniProtKB.
DR   GO; GO:0061564; P:axon development; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISS:UniProtKB.
DR   InterPro; IPR051483; MAP7_domain-containing.
DR   InterPro; IPR008604; MAP7_fam.
DR   PANTHER; PTHR15073:SF3; MAP7 DOMAIN-CONTAINING PROTEIN 2; 1.
DR   PANTHER; PTHR15073; MICROTUBULE-ASSOCIATED PROTEIN; 1.
DR   Pfam; PF05672; MAP7; 1.
DR   neXtProt; NX_Q96T17; -.
DR   PharmGKB; PA162394971; -.
DR   TreeFam; TF332273; -.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Proteomics identification; Reference proteome.
FT   CHAIN           1..732
FT                   /note="MAP7 domain-containing protein 2"
FT                   /id="PRO_0000306809"
FT   REGION          1..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          95..123
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          157..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          210..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          279..509
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          51..146
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..10
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..64
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..345
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        347..357
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        359..374
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        375..386
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        404..509
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..44
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044657"
FT   VAR_SEQ         161
FT                   /note="D -> DGESENTPPPPLGLAASTLPPDAGTTAAAAESTN (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028490"
FT   VAR_SEQ         162..206
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043337"
FT   VAR_SEQ         198..201
FT                   /note="RVFH -> QAEG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028491"
FT   VAR_SEQ         198
FT                   /note="R -> RAHHMHLSPMEAILVSRLLTPTQSSLARSRASVMLSGQANDS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028492"
FT   VAR_SEQ         199..206
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044658"
FT   VAR_SEQ         202..732
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028493"
FT   VARIANT         32
FT                   /note="A -> P (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035450"
FT   VARIANT         182
FT                   /note="N -> S (in dbSNP:rs34519770)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_035313"
FT   CONFLICT        14
FT                   /note="P -> L (in Ref. 3; AAH89400)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        423
FT                   /note="L -> V (in Ref. 1; BAB55093)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        557
FT                   /note="S -> P (in Ref. 1; BAB55093)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        590
FT                   /note="N -> S (in Ref. 1; BAH11884)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q96T17-5:1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
SQ   SEQUENCE   732 AA;  81965 MW;  9F3C004D6942F08E CRC64;
     MERGGGGSGT GSRPEGTARG TSLPGKIAEP GAVRTSQPNY RPQGMEGFLK SDERQRLAKE
     RREEREKCLA AREQQILEKQ KRARLQYEKQ MEERWRKLEE QRQREDQKRA AVEEKRKQKL
     REEEERLEAM MRRSLERTQQ LELKKKYSWG APLAIGPGGH DACDKLSTST MSLPKPTEPP
     MNKRLSSSTV AISYSPDRVF HVCPRLAPLG PLNPSYKSSP TRNIEKKKAT STSTSGAGDV
     GKEALSGGEA SLVEKVKRGQ RTATSLPVVN FGSPLRRCEF SGGIPKRPSS PVISKTATKA
     YPQSPKTTKP PYPGSPVKYR LPALSGQDMP KRKAEKEKSN KEREGTLAQQ AAGPQGEEAL
     EKHVVDKHAS EKHAAAAGGK AENSAALGKP TAGTTDAGEA AKILAEKRRQ ARLQKEQEEQ
     ERLEKEEQDR LEREELKRKA EEERLRLEEE ARKQEEERKR QEEEKKKQEG EEKRKAGEEA
     KRKAEEELLL KEKQEQEKQE KAMIEKQKEA AETKAREVAE QMRLEREQIM LQIEQERLER
     KKRIDEIMKR TRKSDVSPQV KKEDPKVGVQ PAVCVEKKTK LVVPNKMEIN GLNTCQEVNG
     VDHAAPETYP QDIFSNGLKP AGGLIHLDAL DGKSNSLDDS TEEVQSMDVS PVSKEELISI
     PEFSPVSEMI PGVSLDQNGT GNARALQDLL DFTGPPTFPK RSSENLSLDD CNKNLIEGFN
     SPGQETPLNT FC
//
